Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Shafer

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
The Journal of Infectious Diseases|July 1, 1995
Drug resistance and heterogeneous long-term virologic responses of human immunodeficiency virus type 1-infected subjects to zidovudine and didanosine combination therapy. The AIDS Clinical Trials Group 143 Virology TeamR W Shafer, A K Iversen, M A Winters, et al.
AIDS (London, England)|April 1, 1991
HIV prevalence, immunosuppression, and drug resistance in patients with tuberculosis in an area endemic for AIDSR W Shafer, K D Chirgwin, A E Glatt, et al.
Journal of Virology|October 19, 2007
A highly divergent picornavirus in a marine mammalA Kapoor, J Victoria, P Simmonds, et al.
Journal of Virological Methods|March 1, 1993
Zidovudine susceptibility testing of human immunodeficiency virus type 1 (HIV) clinical isolatesR W Shafer, M J Kozal, D A Katzenstein, et al.
Journal of Acquired Immune Deficiency Syndromes|August 1, 1994
HIV-1 syncytium-inducing phenotype, virus burden, codon 215 reverse transcriptase mutation and CD4 cell decline in zidovudine-treated patientsM J Kozal, R W Shafer, M A Winters, et al.
Annals of Internal Medicine|August 15, 1994
Didanosine resistance in HIV-infected patients switched from zidovudine to didanosine monotherapyM J Kozal, K Kroodsma, M A Winters, et al.
Journal of Virology|February 1, 1996
Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapyA K Iversen, R W Shafer, K Wehrly, et al.
Annals of Internal Medicine|December 28, 1999
HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failedA R Zolopa, R W Shafer, A Warford, et al.
The Journal of Infectious Diseases|January 1, 1995
Temporal trends and transmission patterns during the emergence of multidrug-resistant tuberculosis in New York City: a molecular epidemiologic assessmentR W Shafer, P M Small, C Larkin, et al.
AIDS (London, England)|March 1, 1996
Predictors of survival in HIV-infected tuberculosis patientsR W Shafer, A B Bloch, C Larkin, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
The Journal of Infectious Diseases|July 1, 1995
Drug resistance and heterogeneous long-term virologic responses of human immunodeficiency virus type 1-infected subjects to zidovudine and didanosine combination therapy. The AIDS Clinical Trials Group 143 Virology TeamR W Shafer, A K Iversen, M A Winters, et al.
AIDS (London, England)|April 1, 1991
HIV prevalence, immunosuppression, and drug resistance in patients with tuberculosis in an area endemic for AIDSR W Shafer, K D Chirgwin, A E Glatt, et al.
Journal of Virology|October 19, 2007
A highly divergent picornavirus in a marine mammalA Kapoor, J Victoria, P Simmonds, et al.
Journal of Virological Methods|March 1, 1993
Zidovudine susceptibility testing of human immunodeficiency virus type 1 (HIV) clinical isolatesR W Shafer, M J Kozal, D A Katzenstein, et al.
Journal of Acquired Immune Deficiency Syndromes|August 1, 1994
HIV-1 syncytium-inducing phenotype, virus burden, codon 215 reverse transcriptase mutation and CD4 cell decline in zidovudine-treated patientsM J Kozal, R W Shafer, M A Winters, et al.
Annals of Internal Medicine|August 15, 1994
Didanosine resistance in HIV-infected patients switched from zidovudine to didanosine monotherapyM J Kozal, K Kroodsma, M A Winters, et al.
Journal of Virology|February 1, 1996
Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapyA K Iversen, R W Shafer, K Wehrly, et al.
Annals of Internal Medicine|December 28, 1999
HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failedA R Zolopa, R W Shafer, A Warford, et al.
The Journal of Infectious Diseases|January 1, 1995
Temporal trends and transmission patterns during the emergence of multidrug-resistant tuberculosis in New York City: a molecular epidemiologic assessmentR W Shafer, P M Small, C Larkin, et al.
AIDS (London, England)|March 1, 1996
Predictors of survival in HIV-infected tuberculosis patientsR W Shafer, A B Bloch, C Larkin, et al.
Pageof 7